DrugPolicy / Regulatory

CDE Releases 67th Batch of Chemical Generic Reference Preparations

Drug

CDE Releases Guidelines for Chemically Synthesized Peptide Research

CompanyDrug

Junshi Biosciences’ PD-1 Inhibitor Tuoyi Shows Promise in Phase III TNBC Study

CompanyDeals

Abbott Partners with Sinopharm for Expanded Medical Solutions in China

CompanyDrug

Luoxin’s Tegoprazan Gains NMPA Review for Duodenal Ulcer Treatment

CompanyDrug

Shanghai Pharmaceuticals’ X842 Accepted for NMPA Review for Reflux Esophagitis

CompanyDeals

We-Linking Raises Tens of Millions in Angel Round for Brain-Computer Interface

CompanyDeals

Hybio Pharma and CR Medicine Collaborate on Market Expansion

CompanyDrug

Junshi Biosciences Seeks UK MHRA Approval for PD-1 Inhibitor Tuoyi

CompanyDrug

Chinagene Tech Initiates ZVS101e Gene Therapy Trial for Bietti’s Crystalline Dystrophy

CompanyDrug

Ascletis Pharma’s ASC10 Shows Promising Phase I Results at CROI 2023

CompanyDeals

Beijing Huashen Shengdian Secures Angel Funding for Pelvic Surgery Monitor R&D